S&P/TSX Composite Index: Market Falls As Strong CIBC Earnings Fails To Inspire
The S&P/TSX Composite Index (INDEXTSI:OSPTX) fell modestly on Thursday, paring most of its gains to finish negative by 0.10% to 15,508.17. Market volume lagged 3-month averages, as early enthusiasm sparked by strong CIBC earnings failed to hold. Most of the ‘in play’ stocks were decidedly negative.
Leading the way lower was the Healthcare sector, down -1.53% on the day. No individual news stands out, but the sector followed the noticeable lag in American Healthcare stocks versus the broad market. ETF iShares U.S. Healthcare fell 0.27% while the S&P 500 rallied 0.10% and the DJIA 0.66% respectively. Telecoms, Utilities and Financials fell moderately as well.
On a more positive note, Metals & Mining and Energy both rebounded strongly from recent broad-based weakness. Both sectors finished higher by 1.27% and 1.00% respectively.
Despite today’s rally, TSX Energy stocks continue to be down around 14% over the past 12-months. Crude oil finished higher by $0.93c to $62.61/barrel. Valeura Energy Inc., Encana Corporation and Enerplus Corporation led individual names higher.
Metals & Mining has been among the strongest sector on the market, with today’s performance boosting 12-month gains to north of 20%. Pan American Silver Corp., Lundin Mining Corp., and Hudbay Minerals Inc. led individual names higher.
Canadian Imperial Bank of Commerce (TSE:CM): Strong earnings and a 2.3% increase in quarterly dividend to $1.33 per share were enough to trigger buy orders at-open today. The latter means CIBC now pays an annual dividend of $5.32 per share at a 4.5% approximate yield. To cap things off, adjusted EPS rose ten percent in 2018.
Looks like CIBC was playing catch-up to its higher P/E cousins like Royal Bank and TD. Profit taking did occur later on in-line with the broad market afternoon decline.
Conifex Timber Inc. (TSE:CFF): No news, but stock continues to rally off bullish extension from earnings released on February 16. The market obviously like what it saw. Q4 2017 adjusted EBITDA increased to a record $17.5 million from $12.1 million in the previous quarter and $9.3 million in the same quarter of 2016. Overall, adjusted EBITDA was a record $46.0 million, compared to $33.6 million in 2016.
The stock reached fresh 52-week highs on almost 3x average daily volume.
Stantec Inc. (TSE:STN): Analysts maintained a universally poor view of the company’s latest earnings release. Gross revenue came in at $5.14 million, compared to $4.3 million in the prior-year, an increase of 19.5%. Net income registered at $97 million, compared to $130.5 million in the prior-year, a decrease of 25.7%. Stantec Inc. Price finished at the LOD’s, and average volume was 12 times higher than usual.
News Which Moved Markets
▼Clearwater Seafoods Inc. Clearwater announces legal action in light of DFO decision on Arctic surf clam
▲CCL Industries Inc. CCL Industries Announces Record Fourth Quarter and 2017 Results
Chart Of The Day
S&P/TSX Composite Index – Market Summary
|Name||Total Volume||Total Value||Issues Traded||Advancers||Unchanged||Decliners|
|Toronto Stock Exchange||321,556,533||6,578,944,907||1,894||781||270||843|
|TSX Venture Exchange||218,188,855||115,340,464||1,161||349||364||448|
S&P/TSX Composite Index – Most Active
|Bombardier Inc. Class B Subordinate Voting Shares||BBD.B||3.92||0.07||1.82%||3.85||9,343,798|
|Trican Well Service Ltd.||TCW||3.15||-0.31||-8.96%||3.33||7,913,140|
|iShares S&P/TSX 60 Index ETF||XIU||23.00||-0.18||-0.78%||23.16||6,679,357|
|Hydro One Limited Instalment Receipts||H.IR||31.35||-0.50||-1.57%||32.00||6,438,000|
|Cenovus Energy Inc.||CVE||9.31||-0.01||-0.11%||9.41||6,360,486|
|Lundin Mining Corporation||LUN||8.59||0.25||3.00%||8.36||6,187,976|
|Aurora Cannabis Inc.||ACB||10.77||0.05||0.47%||10.62||4,785,182|
|Manulife Financial Corporation||MFC||24.50||-0.28||-1.13%||24.74||4,146,190|
|Toronto-Dominion Bank (The)||TD||73.21||-0.08||-0.11%||73.77||3,704,201|
(Source: TMX Money)
Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.
Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.
Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.